Titanium implant osseointegration with calcium pyrophosphate in rabbits
Source abstract
Abstract
Abstract The objective of this study was to characterize calcium pyrophosphate material, evaluate itsin vitrocytotoxicity, and assess its ability to induce bone formation. X‐ray diffraction (XRD) was used to deterimne crystallinity and phases present in material. Serial dilutions of extracts, from 10‐day dissolution tests in modified Eagle's medium, were exposed for 24 h to mouse fibroblasts and cytotoxicity assessed via viable staining.In vivoperformance was determined by placing Ti screws with and without calcium pyrophosphate agglutinated with marrow adipose tissue in the tibiae of eight rabbits. New bone formation around test and control implants was evaluated histomorphometrically by using three fluorochrome labels: alizarin, calcein, and tetracycline. After 8 postoperative weeks, the animals were killed and specimens were retrieved and processed for fluorescence and light microscopic analysis. Calcium pyrophosphate showed no cytotoxicity and the XRD showed that the main phase of the analyzed sample corresponded to β‐calcium pyrophosphate. The largest fluorochrome labeling area occurred during the fourth and fifth postoperative weeks, in both control and experimental groups. Histologically, the bone neoformation occurred in regions where the calcium pyrophosphate was resorbed. The morphometric analysis showed implants placed with calcium pyrophosphate resulted in smaller polyfluorochrome labeling area (p< 0.05). © 2005 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 2006
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Dental Implant Techniques and Outcomes · Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Garg AK · 1999 · 83
2. 10.1097/00005131-198909000-0000210.1097/00005131-198909000-00002 ↗
3. Bone grafts and growth and differentiation factors for regenerative therapy: a review
4. 10.1007/BF0042606310.1007/BF00426063 ↗
5. 10.1016/0142-9612(93)90026-X10.1016/0142-9612(93)90026-X ↗
6. 10.1016/0142-9612(95)98907-V10.1016/0142-9612(95)98907-V ↗
7. 10.1016/0142-9612(95)99642-Y10.1016/0142-9612(95)99642-Y ↗
8. 10.1016/0142-9612(96)85916-310.1016/0142-9612(96)85916-3 ↗
9. 10.1002/jbm.123810.1002/jbm.1238 ↗
10. Bioceramics: material characteristics versus in vivo behavior10.1002/j.1097-4636.1987.tb00019.x ↗
11. 10.1002/jbm.82025080510.1002/jbm.820250805 ↗
12. State of the art: hydroxyapatite coatings for dental implants
13. 10.1902/jop.1986.57.12.76410.1902/jop.1986.57.12.764 ↗
14. 10.1902/jop.1987.58.2.11010.1902/jop.1987.58.2.110 ↗
15. Immediate placement of implants into periodontally infected sites in dogs: a histomorphometric study of bone‐implant contact
16. ISO.Biological evaluation of medical devices. Part 5. Tests for cytotoxicity: in vitro methods. ISO document 10993;1992.
17. 10.1016/S0142-9612(96)80001-910.1016/S0142-9612(96)80001-9 ↗
18. 10.1046/j.1525-1594.2003.07249.x10.1046/j.1525-1594.2003.07249.x ↗
19. 10.1177/0022034578057003170110.1177/00220345780570031701 ↗
20. Rahn BA · 1976
21. 10.1111/j.1600-0714.1982.tb00172.x10.1111/j.1600-0714.1982.tb00172.x ↗
22. 10.1016/S0278-2391(97)90124-510.1016/S0278-2391(97)90124-5 ↗
23. 10.1097/01.id.0000140462.33075.3410.1097/01.id.0000140462.33075.34 ↗
24. 10.1243/095441198153420410.1243/0954411981534204 ↗
25. 10.1016/S0940-9602(02)80114-510.1016/S0940-9602(02)80114-5 ↗
26. 10.1002/jor.110018022210.1002/jor.1100180222 ↗
27. 10.1016/8756-3282(92)90088-E10.1016/8756-3282(92)90088-E ↗
28. Effects of drill cooling and bone structure on IMZ implant fixation
29. 10.1016/S0940-9602(02)80056-510.1016/S0940-9602(02)80056-5 ↗
30. 10.1002/jbm.b.2000610.1002/jbm.b.20006 ↗
31. Bioactive ceramic prosthetic coatings10.1097/00003086-199203000-00014 ↗
32. 10.1002/jbm.82027011410.1002/jbm.820270114 ↗
33. 10.1016/0142-9612(94)90021-310.1016/0142-9612(94)90021-3 ↗
34. 10.1002/jbm.121310.1002/jbm.1213 ↗
35. 10.1034/j.1600-0501.1998.090301.x10.1034/j.1600-0501.1998.090301.x ↗
36. 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.0.CO;2-J ↗
37. Tissue reaction and material characteristics of four bone substitutes
38. 10.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-610.1002/(SICI)1097-4636(199901)44:1<78::AID-JBM9>3.0.CO;2-6 ↗
39. Short‐term implantation effects of a DCPC‐based calcium phosphate cement
40. 10.1016/S0142-9612(97)00016-110.1016/S0142-9612(97)00016-1 ↗
41. 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P ↗